Carolina Research Professionals, LLC Report issue

For profit Phase 2
Founded: Wilmington DE United States (2013)

Organization Overview

First Clinical Trial
2014
NCT02097303
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasm Metastasis (Phase 2)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4